AUS
NZ
UK
CA
USA
IND
Covid 19
Canada To Receive First Pfizer-BioNTech COVID-19 Vaccine Before December-end
December 08, 2020 06:59 AM EST| By Hina ChowdharySummary Canadians will start getting Pfizer-BioNTech’s COVID-19 vaccine by next week following Health Canada’s approval, Prime Minister Justin Trudeau announced on Monday. PM Trudeau said that about 249,000 doses of the Pfizer vacci.....
Canada Likely To Approve Pfizer-BioNTech COVID Vaccine In 7 to 10 Days
December 04, 2020 11:21 AM EST| By Team Kalkine MediaSummary Health Canada could approve Pfizer Inc’s COVID-19 vaccine in a week’s time, the health regulator said recently. The Canadian government has reserved a supply of more than 400 doses of COVID-19 vaccines from different brands......
Pfizer’s shares plunge after reports of cutting COVID-19 vaccine supply to half
December 03, 2020 11:16 PM EST| By Hina ChowdharyPfizer shares closed the day below 0.22% on Thursday after the news of supply chain challenges. According to several media reports, supply chain challenges forced Pfizer to cut its estimates by half for roll out of the COVID-19 vaccine. The compan.....
Where Does Canada Stand In The Global Queue For COVID-19 Vaccines?
December 02, 2020 07:58 AM EST| By Team Kalkine MediaWith the Pfizer-BioNTech COVID-19 vaccine getting approval in the United Kingdom and the Moderna jab awaiting greenlight in the United States, one may wonder where Canada stands in the line to get the shot. Amid attack from the opposition party an.....
Moderna seeks US, EU approval for COVID-19 vaccine after it demonstrated 94.5% efficacy
November 30, 2020 08:30 PM EST| By Edita IvancevicPharmaceutical giant Moderna Inc. (NYSE:MRNA) intends to ask vaccine regulators in the US, Europe, and the UK for urgent approval of its coronavirus vaccine. According to the company, they performed late-stage study of human trials for the COVID-1.....
.jpg)
What does the new COVID-19 evidence tell us about the future?
November 24, 2020 05:03 AM EST| By Edita IvancevicWinter is coming to the northern hemisphere. Usually, individuals get quite excited around the holidays. However, this year Christmas and New Year might not bring the same amount of joy as they used to. Even after the coronavirus’s first bir.....
Now AstraZeneca-Oxford University COVID-19 Vaccine Shows High Efficacy
November 23, 2020 04:46 AM EST| By Kunal SawhneyNovember is proving to be a super month for global stock markets. The COVID-19 vaccine being developed by the Oxford University and British-Swedish biopharmaceutical firm AstraZeneca (NASDAQ:AZN, AZNCF:US) could be about 90 per cent effecti.....
Asia ratchets up fight against COVID-19 as virus cases resurge
November 23, 2020 02:50 AM EST| By Team Kalkine MediaThe Covid-19 pandemic originated in Asia in Wuhan, China and spread across the world. The first cases of Covid-19 were reported to the WHO on 31 December 2019. These cases reported in Wuhan were the first Covid-19 cases to be reported globally and .....
Moderna’s COVID-19 vaccine impresses, demonstrates 94.5% efficacy
November 16, 2020 09:41 PM EST| By Team Kalkine MediaUS biotech firm Moderna Inc (NASDAQ:MRNA) on 16 November 2020 announced that its experimental vaccine against COVID-19, mRNA-1273 was 94.5% effective, marking a significant breakthrough in the quest to end the ongoing pandemic. The interim data fro.....
.jpg)
Brazil Halts Clinical Trials of Sinovac’s COVID-19 Vaccine, CoronaVac
November 10, 2020 01:26 AM EST| By Team Kalkine MediaAnvisa, the Brazilian health regulator, has paused the Chinese pharmaceutical company Sinovac Biotech Ltd’s (NASDAQ:SVA) COVID-19 final-stage clinical trial. The trials were put on a halt due to the detection of a severe adverse event. .....
Will life return to normal after COVID-19 vaccine?
November 06, 2020 12:04 PM EST| By Hina ChowdharyWith the ongoing rise in the number of COVID-19 cases, the pandemic continues to wreak havoc worldwide. The novel coronavirus has affected more than 47.93 million people, including 1.22 million deaths as per the latest update by the WHO on 5 Novemb.....
COVID-19 Patients fill over 40% of ICU beds in Paris, an alarm bell for Europe?
October 24, 2020 02:08 AM EDT| By Team Kalkine MediaThe ongoing COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to wreak havoc all over the world. According to the WHO, there have been 41.57 million confirmed cases of COVID-19, including 1,134,940 fatalities across the world.....
AstraZeneca (LON:AZN) to resume COVID-19 vaccine trial in the US ahead of elections?
October 22, 2020 06:55 AM EDT| By Team Kalkine MediaAstraZeneca’s COVID-19 clinical trials in the US are anticipated to start again as early as this week after the US Food and Drug Administration (FDA) completed its review of a serious illness, sources told Reuters. As per one of the sou.....
COVID Vaccine Update: Johnson & Johnson and AstraZeneca Vaccines Hit Roadblock, WHO Flags Remdesivir
October 20, 2020 12:14 AM EDT| By Team Kalkine MediaNot only unprecedented, the COVID-19 crisis also seems like a never-ending malaise. While the medical world seems to have no answer to the problem, prominent pharma companies across the globe are racing against time to find the best possible vaccin.....
Trump was gung-ho on Eli Lilly Drug; Company hits pause button for COVID-19 antibody treatment
October 14, 2020 07:33 AM EDT| By Team Kalkine MediaThe clinical trial of pharmaceutical company Eli Lilly and Company’s antibody COVID-19 treatment was paused because of some potential safety concerns. Eli Lilly announced trial halt just a day after Johnson & Johnson disclosed the pause o.....
How are developing world economies preparing for COVID-19 vaccine deployment and testing?
September 30, 2020 05:07 AM EDT| By Team Kalkine MediaThe ongoing COVID-19 pandemic has affected nearly 33.25 million individuals, including ~1 million deaths, as reported to the WHO as of 5:08 PM CEST on 28 September 2020. Many healthcare companies are engaged in the development of vaccines, treatmen.....
COVID-19 vaccine Race: Johnson & Johnson Initiates Global Phase 3 Clinical Trial on 60k Volunteers
September 24, 2020 08:09 AM EDT| By Team Kalkine MediaThe COVID-19 vaccine prospects have intensified with Johnson & Johnson (NYSE:JNJ) disclosing the commencement of its Phase 3 clinical trial (ENSEMBLE) as a COVID-19 vaccine candidate. JNJ’s candidate is the fourth candidate which is under.....
How has COVID-19 affected bitcoin price?
September 15, 2020 06:36 PM AEST| By Edita IvancevicCOVID-19 has brought many fiat currencies into trouble, resulting in disturbed financial markets. For this reason, investors find cryptocurrencies more attractive during unprecedent times, as cryptos do not behave as fiat currencies in the market. .....
.jpg)
Why are AstraZeneca and Pfizer Share Price Under Investors’ Radar?
September 15, 2020 03:28 AM EDT| By Team Kalkine MediaThe COVID-19 storm that has created havoc in the world, is not showing any signs of abating with the world witnessing an ongoing increase in the number of new cases daily. According to the WHO (World Health Organization), globally, there have been .....
Why has AstraZeneca paused its Phase III COVID-19 vaccine study?
September 09, 2020 05:23 AM EDT| By Edita IvancevicWhat was believed to be the most-promising coronavirus vaccine study from AstraZeneca and the University of Oxford has been paused indefinitely, due to the alleged unexplained illness that one of the participants had developed. Phase III vaccine t.....
